Company Profiles

Eventide Funds are invested in companies that are both successful and admirable. The following are examples of companies in the portfolios as of March 31, 2013. Please note the holdings are subject to change:

Domtar
(Ticker: UFS, 1.42% of Gilead Fund net assets)

Domtar Also known as "The Sustainable Paper Company," Domtar is a Fortune 500 company with over $5 billion in annual revenue derived from the paper and pulp industry. Domtar is the largest manufacturer of uncoated free sheet paper (a specialized term for ordinary office and printing paper, and why they chose the ticker UFS) in North America and the second largest in the world. In an era of growing electronic communication, we remember that diplomas, thank you notes, wedding invitations, and professions of love are still best given on paper. On the stewardship front, Domtar has been certified by two independent nonprofit organizations (Forest Stewardship Council and the Sustainable Forestry Initiative) to operate according to the highest industry standards. As another remarkable external endorsement of their practices, Domtar’s EarthChoice product line is supported by the Rainforest Alliance. Excellent management, sustainable practices, and quality products make Domtar an exemplar of a values-based business. (The company is based in Montreal, Canada.)


Red Hat, Inc.
(Ticker: RHT, 0.89% of Gilead Fund net assets)

Red Hat, Inc Red Hat is built upon one of the most intriguing business models among publicly tradeable companies: open-source. Open-s ource software means that all code is freely available for anyone to inspect, improve, or even copy. The flagship open-source program is the operating system Linux, which powers much of the internet, including websites like Google and Amazon.com. Red Hat engineers work with the open-source community by contributing code, "freeze" the code after making it robust, then support their certified version for seven years. Red Hat's customers only buy support (since anyone in the world can freely download all of Red Hat's software). Because Red Hat is only selling support, the company must maintain excellent customer service, since their customers are not obliged to pay for the software or any updates. Red Hat has one of the highest Net Promoter Scores (NPS) in the industry, which has led to consistent growth and annual sales surpassing $1 billion. Their products cover some of the most exciting areas of growth in software including cloud computing, big data, and virtualization. (Red Hat is based in Raleigh, North Carolina.)


NPS Pharmaceuticals
(Ticker: NPSP, 4.32% of Gilead Fund net assets; 3.42% of Healthcare & Life Sciences Fund net assets)

NPS Pharmaceuticals Imagine a life where a portion of your intestine had to be removed, or is so diseased, that your primary source of nutrition comes intravenously, so-called PN (parenteral nutrition).  Besides humiliating and unremitting diarrhea, every night you have to attach yourself to tubing so that you can be fed.  This causes you to have to get up often in the night to use the bathroom because of the fluid intake.  Unable to get a good night's rest, you become further debilitated and often suffer from depression.  One patient on PN said, "I cannot stay out too long because of my demanding PN schedule, which requires me to receive treatment seven nights each week for 10 hours at a time."  Another said, "A treatment that would give me back just a night or two a week would greatly improve my life.  Maybe even one day, I can travel again."  By modifying a natural peptide hormone, NPS Pharmaceuticals has developed a candidate drug, Gattex, that causes intestinal cells to divide and become healthier.  The result is that patients have a significantly reduced, or sometimes even eliminated, need for intravenous nutrition.  NPS boldly approached a patient group without any recourse, and is bringing them hope for much improved quality of life.  The FDA will issue an approval decision for Gattex in December 2012.  (The company is based in Bedminster, NJ.)

 

Eventide Asset Management, LLC is the Adviser to Eventide Mutual Funds. An investor should consider a fund's investment objectives, risks, charges and expenses carefully before investing or sending money. This and other important information can be found in the prospectus of the fund. Please read the prospectus carefully before investing. Eventide Mutual Funds are distributed by Northern Lights Distributors, LLC, Member FINRA, which is not affiliated with Eventide Asset Management, LLC.


1717-NLD-10/25/2012